Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold... see more

CSE:SONA - Post Discussion

Sona Nanotech Inc > Reality folks
View:
Post by Chyler1 on Dec 31, 2020 10:10pm

Reality folks

No sales contracts and no mention of any 
company will only update on sales every quarter meaning next update March 31
Roche and Abbott have already squeezed out all other antigen tests in Europe of which there are many all with Ce mark 
price Roche and Abbott are selling for in Europe is $6 USD
Why would European customers be interested in Sona when there are so many other tests in the market including Roche and Abbott who have fda and hc approvals and have already signed big contracts ?
HC said they wanted more data before they would consider test 
FDA said they weren't interested in approving their test as EUA 
havent started clinical trials yet for  resubmission to HC or fda for nasalpharyngal test

Haven't completed prototype yet for saliva test 
may least one lawsuit has been filed against the company 


tell me again why anyone other than a short would be interested in this stock right now with a $200m+ market cap ?  Just asking

Comment by Waco4505 on Dec 31, 2020 10:23pm
If there was no interest there would not be approval.   Period
Comment by Chyler1 on Dec 31, 2020 10:40pm
That's completely false. CE marking is not contingent upon sales contracts (or interest)   Please send me link that shows what you are claiming.  I will save you the effort. There are numerous companies with antigen tests with CE marking who haven't sold one test. If you believe what you said and you are invested you better check your facts 
Comment by ACEJackSuited on Dec 31, 2020 11:12pm
This post has been removed in accordance with Community Policy
Comment by willywonka on Dec 31, 2020 11:29pm
Did you expect anything different from a facking politician ?
Comment by dart321 on Dec 31, 2020 11:45pm
Chyler1 are you that short, hurting real bad or are you working for the Law Firms. There will be no grounds if the share price goes back to where it was. My god man if you are short and they announce any type of sales next week you're in a real world of hurt.
Comment by willywonka on Jan 01, 2021 10:15am
If SONA is smart, they should eventually sue the Law Firms for defamation.
Comment by willywonka on Jan 01, 2021 10:17am
I would really like to see some of these Ambulance chasers get their due. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities